Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 36 pages

IgA Nephropathy (Bergers Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

IgA Nephropathy (Bergers Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY IgA Nephropathy (Berger's Disease) Drugs in Development by Stages, Target, MoA...

May 2022 73 pages

IgG Receptor FcRn Large Subunit p51 (IgG Fc Fragment Receptor Transporter Alpha Chain or Neonatal Fc Receptor or FCGRT or FCRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

IgG Receptor FcRn Large Subunit p51 (IgG Fc Fragment Receptor Transporter Alpha Chain or Neonatal Fc Receptor or FCGRT or FCRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...

May 2022 38 pages

IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Develo...

May 2022 49 pages

Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by...

May 2022 38 pages

Inducible T Cell Costimulator (Activation Inducible Lymphocyte Immunomediatory Molecule or CD278 or ICOS) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Inducible T Cell Costimulator (Activation Inducible Lymphocyte Immunomediatory Molecule or CD278 or ICOS) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 39 pages

Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA...

May 2022 39 pages

Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 42 pages

Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 36 pages

Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 170 pages

Influenza M2 Proton Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Influenza M2 Proton Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Influenza M2 Proton Channel Drugs in Development by Therapy A...

May 2022 36 pages

Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 269 pages

Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA,...

May 2022 46 pages

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Insulin Like Growth...

May 2022 65 pages

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Insulin Receptor (IR or CD220 or IN...

May 2022 219 pages

Integrin Alpha 2b (GPalpha IIb or Platelet Membrane Glycoprotein IIb or CD41 or ITGA2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Alpha 2b (GPalpha IIb or Platelet Membrane Glycoprotein IIb or CD41 or ITGA2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY I...

May 2022 36 pages

Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Alpha V (...

May 2022 67 pages

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type an...

May 2022 48 pages

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 3 (P...

May 2022 57 pages

Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and...

May 2022 35 pages

Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and...

May 2022 37 pages

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Inte...

May 2022 39 pages

Interferon Alpha-Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha-Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1) Drugs in Development by Therapy Areas and Indica...

May 2022 82 pages

Interferon Alpha-Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha-Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 72 pages

Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and...

May 2022 41 pages

Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Beta (Fibroblast Inte...

May 2022 36 pages

Interferon Gamma (Immune Interferon or IFNG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Gamma (Immune Interferon or IFNG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Gamma (Immune Interferon or IFNG)...

May 2022 37 pages

Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Gamma Receptor 1 (CDw1...

May 2022 35 pages

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Alpha (IL 1 Alp...

May 2022 40 pages

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Beta (IL 1 Beta or Cata...

May 2022 56 pages

Interleukin 1 Receptor Accessory Protein (Interleukin 1 Receptor 3 or IL1R3 or IL1RAP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor Accessory Protein (Interleukin 1 Receptor 3 or IL1R3 or IL1RAP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY In...

May 2022 38 pages

Interleukin 1 Receptor (IL1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor (IL1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Receptor (IL1R) Drugs in Development by Thera...

May 2022 73 pages

Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 38 pages

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 10 (Cyt...

May 2022 49 pages

Interleukin 10 Receptor (IL10R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 10 Receptor (IL10R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 10 Receptor (IL10R) Drugs in Development by T...

May 2022 42 pages

Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 12 (IL12) Drugs in Development by Therapy Areas and Ind...

May 2022 89 pages

Interleukin 12 Receptor (IL12R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 12 Receptor (IL12R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 12 Receptor (IL12R) Drugs in Development by T...

May 2022 52 pages

Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 13 (IL13) Drugs in Development by Therapy Areas and Ind...

May 2022 40 pages

Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 15 (IL15) Drugs in Development by Therapy Areas and Ind...

May 2022 62 pages

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 15 Receptor Subunit A...

May 2022 62 pages

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleuk...

May 2022 57 pages

Interleukin 17F (Cytokine ML 1 or IL17F) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 17F (Cytokine ML 1 or IL17F) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 17F (Cytokine ML 1 or IL17F) Drugs i...

May 2022 37 pages

Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 18 (Interferon Gamma Inducing Factor or Iboctadekin or Interleukin 1 Gamma or IL18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 37 pages

Interleukin 2 Receptor (IL2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Interleukin 2 Receptor (IL2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2 Receptor (IL2R) Drugs in Development by Thera...

May 2022 134 pages

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2...

May 2022 46 pages

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 2 (T Cell Growth F...

May 2022 55 pages

Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 21 Receptor (Novel Interleukin Receptor or CD360 or IL21R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 21 Rec...

May 2022 39 pages

Interleukin 22 Receptor (IL22R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 22 Receptor (IL22R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 22 Receptor (IL22R) Drugs in Development by T...

May 2022 39 pages

Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 23 (IL23) Drugs in Development by Therapy Areas and Ind...

May 2022 61 pages

Interleukin 23 Receptor (IL23R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 23 Receptor (IL23R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 23 Receptor (IL23R) Drugs in Development by T...

May 2022 36 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...